PubMed=7251319
John T. Isaacs, George W. Yu, Donald Straley Coffey;
The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor.
Invest. Urol. 19:20-23(1981)

PubMed=3774632; DOI=10.1002/pros.2990090306
John T. Isaacs, William B. Isaacs, Wouter F.J. Feitz, Jacques Scheres;
Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers.
Prostate 9:261-281(1986)

PubMed=3174494; DOI=10.1002/pros.2990130208
John T. Isaacs, Bharati Hukku;
Nonrandom involvement of chromosome 4 in the progression of rat prostatic cancer.
Prostate 13:165-188(1988)

PubMed=7910810; DOI=10.1002/ijc.2910570519
Imtiar Bashir, Karol Sikora, Paul Abel, Christopher S. Foster;
Establishment and in vivo characterization of multidrug-resistant Dunning R3327 rat prostate-carcinoma cell-lines.
Int. J. Cancer 57:719-726(1994)

PubMed=8687134
Prakash K. Pandalai, Mary Jo Pilat, Kosuki Yamazaki, Harmesh Naik, Kenneth James Pienta;
The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth.
Anticancer Res. 16:815-820(1996)

PubMed=23467722; DOI=10.3892/or.2013.2323
Ewa Musialik, Damian Ryszawy, Zbigniew Madeja, Wlodzimierz Korohoda;
Morpho-physiological heterogeneity of cells within two rat prostate carcinoma cell lines AT-2 and MAT-LyLu differing in the degree of malignancy observed by cell cloning and the effects of caffeine, theophylline and papaverine upon a proportion of the clones.
Oncol. Rep. 29:1789-1796(2013)